Navigating the Complexities of Cell and Gene Therapy Supply Chains
Cell and gene therapies (CGTs) promise breakthrough treatments but demand highly complex supply chains. The process spans cell collection, manufacturing, temperature‑controlled transport, and delivery, requiring strict regulatory compliance and real‑time data integrity. Developers face challenges such as cold‑chain logistics, stakeholder coordination, and scaling. Catalent’s Case Management Services offers end‑to‑end coordination, risk mitigation, and proven time‑reduction results, positioning it as a strategic partner for CGT programs.
BullFrog AI to Unveil New Precision AI Capability
BullFrog AI announced a new scenario‑based decision engine to be released on March 25, adding a strategic layer to its bfPREP™ and bfLEAP® platforms. The engine compares drug programs, indications, and trial designs without forcing single numeric scores, and evaluates portfolio...
Zydus Lifesciences Posts 30% Revenue Jump in Q3, Net Profit up 9%
Zydus Lifesciences reported a 30% year‑on‑year revenue increase to ₹68.6 bn in Q3 FY2025‑26, driven by strong performance across pharmaceuticals, consumer wellness and medtech. Adjusted net profit rose 9% to ₹11.1 bn, while EBITDA grew 31% to ₹18.2 bn, lifting margins to 26.5%....
Strong Clinical Data for Breye Lead Asset Danegaptide
Breye Therapeutics presented early-phase data on its oral small‑molecule danegaptide for non‑proliferative diabetic retinopathy (NPDR). In a multi‑centre phase 1b study of 24 patients, the drug was well tolerated and achieved plasma concentrations within the target range. More than half of...
Lilly Returns to Innovent to Partner on Cancer and Immune Diseases
Eli Lilly has deepened its alliance with China‑based Innovent Biologics, signing a new agreement that includes a $350 million upfront payment. The partnership will focus on co‑developing bispecific antibody candidates targeting oncology and immunology indications. Both companies will share development costs, milestone...
Biotech Startup Pandorum Technologies Raises $18 Mn in Series B Round
Pandorum Technologies, an Indian‑US biotech focused on exosome‑based regenerative therapies, closed an $18 million Series B round led by Protons Corporate. The round, completed in two tranches, values the company at roughly $91 million post‑money, bringing total capital raised to about $43 million. Proceeds...
The Peptide Craze Sweeping America Has a Fan in RFK Jr
The U.S. wellness market has been flooded with unapproved "pop" peptides such as BPC‑157, GHK‑Cu and TB‑500, prompting the FDA in 2023 to reclassify most of them as Category 2, effectively banning their compounding. Despite the ban, a gray‑market supply chain—often...
Elevate Now Raises Rs 18 Cr in Seed Round Led by Physis Capital
Elevate Now, a doctor‑led clinical weight‑loss platform, secured Rs 18 crore in a seed round headed by Physis Capital, with Inflection Point Ventures and Titan Capital also participating. The Bengaluru startup previously raised $2 million in a pre‑seed round from W Health Ventures,...
Global HealthX Crosses $15 Mn in Healthcare Investments, Unveils Startup Cohort
Global HealthX, the venture studio of the Global University Foundation, announced it has surpassed $15 million in investments across Indian healthcare and life‑science startups over the past two years. The latest cohort features five companies—TapHealth, Wellytics, Monitra Health, Merry Health and...
FDA Policy Tracker 2026: Priority Vouchers Questioned, PRVs Return
2026 regulatory landscape sees the FDA reviving the rare‑pediatric disease priority review voucher (PRV) program, launching the PreCheck manufacturing pilot, and issuing new guidance for multiple myeloma trials and GLP‑1 label warnings. The PRV reinstatement restores a $150 million voucher market,...
Cerebellar Microglia-Derived IL-17A Mitigates Autism-Related Behavioral and Synaptic Deficits
Researchers discovered that cerebellar microglia are the sole source of elevated interleukin‑17A (IL‑17A) in a Fragile X mouse model of autism. The microglia‑derived IL‑17A restores Purkinje cell firing rates and normalizes synaptic inhibition, leading to improved social interaction and reduced...
The Many-to-Many Problem of Endophenotypes in Psychiatry - a Biological Perspective
The article argues that current psychiatric diagnostic systems and neuroimaging endophenotypes fail to capture the underlying biological complexity of mental illness. Genetic studies reveal extensive pleiotropy and overlapping risk loci across disorders, while neurotransmitter systems exhibit strong spatial colocalization, creating...
Correction: Microbiota Is Essential for Social Development in the Mouse
A correction notice was issued for the Molecular Psychiatry article that originally linked gut microbiota to social development in mice. The wrong image was published as Figure 1a and has now been replaced with the correct visual, while Figure 1b and the...
Circuit-Informed Modulation of Traumatic Memory in PTSD: Integrating Extinction, Suppression, and Reconsolidation
A new review synthesizes recent circuit‑level findings to propose an integrated model for modulating traumatic memories in PTSD. It combines extinction, memory suppression, and reconsolidation mechanisms, emphasizing the amygdala‑prefrontal‑hippocampal network and its neuromodulatory inputs. The authors highlight how this framework...
GLP-1s Are an Environmental Catastrophe
GLP‑1 agonists such as Ozempic have surged in popularity for weight loss, but their peptide‑based manufacturing generates massive environmental waste. Current solid‑phase peptide synthesis (SPPS) relies on toxic organic solvents, producing over 123 million pounds of waste annually for semaglutide alone....
ByteDance Releases Protenix-V1: A New Open-Source Model Achieving AF3-Level Performance in Biomolecular Structure Prediction
ByteDance unveiled Protenix‑v1, an open‑source, AlphaFold3‑style foundation model for all‑atom biomolecular structure prediction covering proteins, nucleic acids and ligands. The 368 million‑parameter system matches AlphaFold3’s training data cutoff, model scale and inference budget, and claims superior performance on curated benchmarks. Protenix...
Flickstop
A recent BMJ article outlines a comprehensive telesurgery architecture comprising robot, telecommunication, and teleconference subsystems. The design employs a dedicated line with a backup path to link the surgeon console and patient cart, while a secondary console resides in the...
India Has Changed Its Startup Rules for Deep Tech
India has overhauled its startup framework, extending deep‑tech status to 20 years and raising the revenue eligibility threshold to ₹3 billion. The change dovetails with a ₹1 trillion Research, Development and Innovation fund and the $1 billion‑plus India Deep Tech Alliance, aimed at easing...
Doctors Overprescribe Personalized Semaglutide, Raising Legal Red Flags
Oh and it’s been a while since this topic has come up, but, to the $HIMS-employed doctors/nurse practitioners etc who have been writing millions of “personalized” doses of semaglutide nonstop in order to help the company skirt intellectual property rights: Do...
All Pharma Will Secure Chinese Clinical Development Partner Soon
Within the next 18-24 months every Pharma will have a partner to access the China fast clinical development engine https://t.co/zpLV1XJbvB https://t.co/h5CyXUNO82
SpaceX Crew-12 Will Study How Microgravity Affects the Human Body
NASA’s Crew‑12 mission will launch aboard SpaceX’s Crew Dragon on Feb. 11, carrying two NASA astronauts, an ESA specialist, and a Russian cosmonaut. While aboard the ISS, the crew will conduct the Venous Flow study to assess blood‑clot risk and a...
#ACTRIMS26: Sanofi Unpacks Data From a Failed Phase 3 Tolebrutinib Trial in PPMS
Sanofi disclosed results from its Phase 3 trial of the BTK inhibitor tolebrutinib in primary progressive multiple sclerosis (PPMS). The study failed to meet its primary endpoint of slowing disability progression, and secondary outcomes showed no meaningful benefit. Safety data...
Exposure to Grilled Lamb‐Borne Carbon Quantum Dots Induces Intrahepatic Cholestasis by Activating the Intestinal Microbial‐Derived Lipopolysaccharide‐TLR4 Pathway
Researchers discovered that carbon quantum dots (CQDs) released from grilled lamb accumulate in mice after nine weeks of oral exposure at 25 mg kg⁻¹, damaging liver and intestinal barriers. The CQDs elevate gut‑derived lipopolysaccharide, triggering the intestinal LPS‑TLR4‑MyD88 signaling cascade and hepatic...
Advanced Photoporation: Micro‐Nanostructures for Size‐Specific Highly Efficient Biomolecular Delivery
Photoporation is emerging as a versatile, non‑viral platform for intracellular delivery, and a new review proposes a size‑centric framework that categorises strategies by cargo dimensions rather than by laser or material type. The authors analyse how micro‑ and nanostructured substrates...
Biocompatible Glue‐Enabled Drug Localization and Mechanical Reinforcement of Lyophilized Microneedle Systems
The Lyophilized Microneedle System with Biocompatible Glue (LMS‑BG) integrates a porous, drug‑loaded microneedle tip with a biodegradable ethanol‑based glue to create a mechanically robust, ultra‑fast dissolving transdermal platform. In tests using lidocaine, the system dissolved 11‑times faster than conventional dissolving...
Dynamically Reprograms Mitochondrial Respiration to Augment Cuproptosis in Cancer Therapy
Researchers engineered a copper‑coordinated polymer that transports lactate oxidase into cancer cells, converting intracellular lactate to pyruvate. This metabolic shift elevates mitochondrial respiration, sensitizing tumors to copper‑driven cuproptosis. Simultaneously, copper triggers DLAT oligomerization and a Fenton‑like reaction, inducing ferroptosis. In...
NBD Integrated and Vitamin B6‐Driven Charge‐Reversible Peptide‐Based Nanocarriers for Targeted Therapeutic Delivery
Researchers have engineered a phenylalanine‑tryptophan dipeptide nanocarrier functionalized with the fluorescent probe NBD and a vitamin B6‑derived pH‑responsive unit. The self‑assembled nanospheres load doxorubicin with high efficiency and undergo charge reversal at mildly acidic pH, triggering rapid drug release and nuclear...
Dual Therapeutic Effects of Ultra‐Small Platinum‐Selenium Nanoparticles on Oxalate‐Induced Acute Kidney Injury
Researchers synthesized ultra‑small platinum‑selenium (Pt‑Se) nanoparticles that effectively halt calcium oxalate (CaOx) crystal nucleation and growth, reducing crystal‑cell interactions and oxidative damage. In vitro assays demonstrated strong inhibition of CaOx crystallization, while a hyperoxaluria mouse model showed markedly lower renal...
Fluorescently Labeled Gradient Hydrogels Reveal Matrix‐Dependent Cell Responses to Substrate Stiffness
Researchers introduced a thermophoresis-based method to fabricate fluorescently labeled stiffness gradient hydrogels, enabling contactless stiffness mapping via standard microscopy. The technique leverages fluorescein isothiocyanate labeling, where fluorescence intensity reflects polymer concentration and thus stiffness. Experiments with gelatin methacryloyl (GelMA) and...
'A Second Set of Eyes': AI-Supported Breast Cancer Screening Spots More Cancers Earlier, Landmark Trial Finds
A prospective, population‑based MASAI trial in Sweden screened over 100,000 women using a commercially available AI system alongside radiologists. The AI‑assisted workflow identified more clinically relevant breast cancers and cut interval‑cancer rates without raising false‑positive alerts. Radiologists read AI‑flagged cases...
Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model
Scientists have identified two small‑molecule inhibitors—SHY1643 targeting the SARS‑CoV‑2 papain‑like protease (PLpro) and QY1892 targeting the host kinase RIPK1—that together produce a potent antiviral effect in a mouse COVID‑19 model. Individually, each compound modestly reduced viral loads and inflammation, but...
McKinsey Vet Franck Le Deu Joins Nisa Leung’s New Fund; Plus C-Suite Shuffle at Bicycle
Former McKinsey senior partner emeritus Franck Le Deu has joined Aulis Capital as a venture partner. Aulis, the Hong Kong‑based fund launched by veteran Chinese VC Nisa Le Ung, will back emerging biotech and health‑tech companies across Asia and the West. Le Deu, who...
Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease
A new multidisciplinary, evidence‑based guideline set recommends therapeutic drug monitoring (TDM) for biologic therapies in inflammatory bowel disease (IBD). The recommendations integrate pharmacokinetic data, disease activity metrics, and patient‑specific factors to optimize dosing of anti‑TNF, anti‑integrin, and anti‑IL agents. The...
Series A Companies: Biotech’s Class of 2025
After four years of falling series A activity, biotech start‑up financing stabilized in 2025. The number of companies raising series A remained flat versus 2024, while total dollars raised increased. BioCentury’s analysis shows a broader revival, with round sizes, investor profiles, and...
FDA Clears First Human Cellular Reprogramming Trial
Fascinating interview with Chief Scientist Sharon Rosenzweig-Lipson about working with the FDA, prepping for clinical trials, and what's next lifespan.io/news/first-human-cellular-reprogramming-trial-cleared-by-the-fda/
Inspect Your P‑value Histogram After DESeq2 Analysis
How is your p-value histogram look like? chatomics blog post: Downstream of bulk RNAseq: read in salmon output using tximport and then DESeq2 https://t.co/zGjobde9TO https://t.co/aCJaxto5tS
Structure-Guided Development of Picomolar Macrocyclic Inhibitors Targeting TRPC5 Channels with Antidepressant Effects
Scientists have created a new class of macrocyclic inhibitors that target the TRPC5 ion channel with picomolar potency. The lead compound JDIC‑127 achieves an IC₅₀ of 374 pM, roughly 200‑fold more potent than the previous benchmark HC‑070, and demonstrates high selectivity...
Circulating Mitochondrial and Cellular Damage Markers in Long COVID: Links to Cognitive Function, Psychological Distress, and Inflammation
A recent Molecular Psychiatry study measured circulating mitochondrial DNA and other cellular damage markers in individuals with long COVID and found them significantly elevated compared with recovered controls. The analysis revealed strong correlations between higher mtDNA levels and reduced performance...
A Color-Changing Microneedle Sensor Made From Food Ingredients Can Detect Spoilage Through Sealed Packaging
Researchers have created a food‑safe gelatin microneedle sensor that pierces sealed packaging and changes color as protein‑rich foods spoil. The device embeds red‑cabbage anthocyanin, shifting from purple to blue when pH rises, providing a visual spoilage cue. Mechanical tests show...
US Calls for DOJ Investigation of Hims over GLP-1 Drugs
The U.S. government has referred tele‑health firm Hims & Hers to the Department of Justice for a formal investigation into its GLP‑1 weight‑loss program. Hims, which recently launched a compounded version of GLP‑1 drugs to compete with Novo Nordisk’s market‑leading injectables, is...
Sanofi Misses in Fabry: Is It Time to Move on From GCS Inhibition in the Indication?
Sanofi announced that its glucosylceramide synthase (GCS) inhibitor for Fabry disease failed to meet the primary efficacy endpoint in a late‑stage trial. The double‑blind study enrolled roughly 280 patients and showed no statistically significant improvement in key renal or cardiac...
Regulators Target Hims After Misleading GLP‑1 Ads
Coincidence that $HIMS has suddenly taken down all ads touting “the same active ingredient as Wegovy”? $HIMS may have finally called enough attention to their bullshit antics to get regulators to finally crack down on them. This could...
Study Reveals Modulated UV-C Light Extends Guava Shelf Life
A recent study demonstrates that applying modulated UV‑C light to harvested guavas can significantly prolong their shelf life. The researchers found that pulsed UV‑C treatment suppresses microbial growth while using roughly 30% less energy than continuous exposure. Shelf life extensions...
Flu B Surge Kills 8 More Children, 90% Unvaccinated
1. Some news about #flu & #measles in the US: 8 more kids have died from flu this winter. That brings the pediatric death toll to 60 & flu season isn't over. Flu B activity seems to be increasing & flu...
TrumpRx Launch Falls Flat for some, Citing Generic Access
President Donald Trump unveiled TrumpRx, a direct‑to‑consumer drug platform promising to let Americans purchase prescription medicines without traditional insurance intermediaries. The rollout was framed as a fulfillment of broken political promises to lower drug costs. However, early feedback highlights that...
New Discovery Reveals Why Ovarian Cancer Spreads Rapidly in the Abdomen
Recent research highlights AI‑driven discovery of tetrahydrocarbazoles as click‑activated, broad‑spectrum antitumor agents, while a plant‑derived limonoid, DHL‑11, targets IMPDH2 to inhibit triple‑negative breast cancer. A U.S. survey shows patients still favor in‑clinic cervical cancer screening over home tests, and a...
New Study Uncovers Mechanism Behind Burn Pit Particulate Matter–Induced Lung Inflammation
Researchers at National Jewish Health published a study showing that particulate matter from military burn pits provokes markedly stronger inflammatory and oxidative responses in lung macrophages than ordinary desert dust. The work identifies Toll‑like Receptor 2 (TLR2) as the primary sensor...
Arguing for a Higher Heritability of Human Longevity
A new open‑access study re‑examines human longevity heritability, arguing that previous estimates were biased low because they ignored extrinsic mortality and arbitrary age cutoffs. By modeling and correcting for these factors, the authors find intrinsic lifespan heritability rises to roughly...
HHS Drops Legal Fight over Blocked 340B Rebate Pilot
The U.S. Department of Health and Human Services has abandoned its legal challenge to a federal court’s injunction that halted a proposed 340B drug‑price rebate pilot. The pilot, designed by the Trump administration to test new rebate mechanisms for hospitals...
Orphan Drug Tweak in US Spending Bill Will Make Life Easier for the FDA
President Donald Trump signed the federal spending bill preserving the FDA’s ability to grant a seven‑year exclusivity period for orphan drugs that receive new indications. The provision reverses earlier suggestions to shorten the exclusivity term, embedding the policy in the...